[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Standard Process Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":74},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100647685","diaplex-and-glycemic-control-100647685",false,"NCT07711587","Diaplex and Glycemic Control","A Pilot Study Investigating the Effects of Diaplex Supplementation on Glucose Regulation in Otherwise Healthy Adults With Elevated Blood Glucose Levels","Inclusion Criteria • Adults 30-65 years old with elevated average blood glucose levels (100-125 mg\u002FdL), confirmed at screening (HbA1c 5.7-6.4%)\n\n• BMI 18.5-29.9 kg\u002Fm² (normal to overweight)\n\n• Generally healthy individuals with no metabolic or endocrine disorders besides elevated blood glucose levels, meaning no metabolic syndrome, insulin resistance diagnosis, dyslipidemia diagnosis requiring treatment, thyroid disorders, etc.\n\n• Stable weight for the past 3 months (±5%)\n\n• Sedentary or lightly active baseline lifestyle (Light activity ≤3 times\u002Fweek (e.g., walking, yoga, casual biking)\n\n• Willingness to maintain usual diet, activity, and sleep patterns for 16 weeks\n\n• Able and willing to wear a CGM for the final 10-14 days\n\n• Willing to complete 3-day dietary recalls, sleep and activity logs\n\n• Not taking or willing to stop taking supplements containing chromium, vitamin A, vitamin B6, iodine, and niacin\n\n• Able and willing to provide informed consent and complete all study visits 6 Exclusion Criteria\n\n• Any diagnosed metabolic\u002Fendocrine disorder, other than elevated blood glucose levels, such as metabolic syndrome, insulin resistance diagnosis, clinically significant dyslipidemia, thyroid dysfunction or use of thyroid medication, or obesity-related endocrine dysfunction\n\n• Medications and supplements use of glucose-lowering medications within the past 3 months, including use of weight-loss drugs or metabolic agents, such asGLP-1 RAs (Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda) or GIP\u002FGLP-1 RAas (Mounjaro, Zepbound)\n\n• Use of supplements within the last 30 days containing chromium, vitamin A, vitamin B6, niacin, iodine\n\n• Unwilling to discontinue prohibited supplements\n\n• Health Conditions \\& safety such as elevated ALT\u002FAST more than 2× the upper limit or known chronic liver disease or diagnosed renal impairment (eGFR \\\u003C45 mL\u002Fmin\u002F1.73 m²), uncontrolled hypertension (\\>160\u002F100 mmHg)\n\n• Pregnant, breastfeeding, or planning pregnancy\n\n• Allergy or sensitivity to study ingredients or CGM adhesives\n\n• Lifestyle and compliance (\\>30 minutes\u002Fday of intense physical activity (active adults or athletes))\n\n• Participation in another investigational trial in the past 30 days\n\n• Any condition that may interfere with participation or data quality (per investigator guidance)",true,"ALL","30 Years","65 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this 16-week double-blind, placebo-controlled pilot study is to determine whether daily Diaplex supplementation improves insulin sensitivity and glycemic control in adults with elevated blood glucose levels, while generating high-quality preliminary data on metabolic effects, glycemic patterns, and safety to inform future trials",[28,29],"Insulin Sensitivity","Healthy Adult",[31,32,33],"Supplement","Chromium","Glycemic Index","NOT_YET_RECRUITING","2026-07-13",{"date":37,"type":38},"2026-07-17","ACTUAL",{"date":40,"type":22},"2026-09-01",{"date":42,"type":22},"2027-12-15",{"name":44,"class":45},"Standard Process Inc.","INDUSTRY",{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":16,"sex":17,"minAge":54,"maxAge":19,"enrollmentInfo":55,"targetDuration":4,"studyType":23,"phases":57,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},"100621513","royal-ancient-oats-study-100621513","NCT07371598","Royal Ancient Oats™ Study","Impact of Royal Ancient Oats™ on Glycemic Response and Digestive Enzymes","RAO","Inclusion Criteria:\n\n* Non-diabetic (HbA1c\\\u003C5.7%) adults both men and women between the ages of 35-65 years with body mass index (BMI) ranging from 25 to 30 kg\u002Fm2\n* Participants who meet the inclusion criteria will be screened prior to starting the study and must be able to adhere to the requirements of the study.\n* Willing to comply with study procedures and supplement regimens.\n* Providing consent to participate in the study.\n* Willing to limit\u002Fminimize foods that are rich sources of fiber and high carb content.\n* Participants should avoid taking any non-prescription\u002Fover-the-counter medications or nutritional supplements that could influence glycemic response. This includes vitamins, herbal supplements, and any medications affecting metabolism. Examples include probiotics and prebiotics, vit D, vit B12, Ginseng, fenugreek, weight loss supplements like green tea extract and Garcinia cambogia, fiber supplements like inulin and Psyllium husk. If participants need to make any changes due to health reasons, they should consult with the study coordinator before doing so.\n\nExclusion Criteria:\n\n* Participants who have experienced weight loss or gain exceeding 5% of their body weight in the past 3 months, including those involved in any weight loss or weight gain programs through diet and\u002For lifestyle changes.\n* Participants currently taking medications that could alter metabolism, such as weight loss medications, anti-hypertensive drugs, or lipid-lowering medications.\n* Participants with any chronic metabolic diseases, including diabetes, or those using supplements other than a daily multivitamin.\n* Pregnant or lactating women will be excluded from the study.\n* Participants who use tobacco products.\n* Participants who are unwilling to limit or minimize foods that are rich sources of fiber and high carbohydrate content.\n* Excessive alcohol consumption (e.g., more than two drinks per day for men and more than one drink per day for women)\n* Inconsistency in recent or planned changes in non-prescription\u002Fover-the-counter medications or nutritional supplements affecting glycemic response, including vitamins (e.g., Vitamin D, Vitamin B12), herbal supplements (e.g., Ginseng, Fenugreek), weight loss supplements (e.g., green tea extract, Garcinia cambogia), fiber supplements (e.g., inulin, psyllium husk), and probiotics\u002Fprebiotics.\n* Inability or unwillingness to maintain the current regimen of these medications and supplements throughout the study period without consulting the study coordinator.","35 Years",{"count":56,"type":22},38,[25],"Evaluating the effects of high avenanthramide ancient oat (Royal Ancient Oats™) muffins versus conventional oat muffins in regard to glycemic control.",[60,61],"Healthy Participants","Healthy Glucose",[63],"healthy glucose","RECRUITING","2026-01-19",{"date":67,"type":38},"2026-01-28",{"date":69,"type":38},"2026-01-13",{"date":71,"type":22},"2026-09-15",{"name":44,"class":45},1,""]